{"id":43344,"date":"2020-10-19T00:00:00","date_gmt":"2020-10-19T00:00:00","guid":{"rendered":"https:\/\/discover.restek.com\/uncategorized\/high-throughput-analysis-of-immunosuppressive-drugs-from-whole-blood-by-lc-msms\/"},"modified":"2025-12-12T15:02:36","modified_gmt":"2025-12-12T15:02:36","slug":"high-throughput-analysis-of-immunosuppressive-drugs-from-whole-blood-by-lc-msms","status":"publish","type":"post","link":"https:\/\/discover.restek.com\/de\/application-notes-it\/cfan2666\/high-throughput-analysis-of-immunosuppressive-drugs-from-whole-blood-by-lc-msms","title":{"rendered":"High-Throughput Analysis of Immunosuppressive Drugs from Whole Blood by LC-MS\/MS"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Abstract<\/h2>\n\n\n\n<p>The success of organ transplant therapy depends in large part on the accurate and timely analysis of immunosuppressive drugs. In this study, we developed a fast, accurate method for the analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood. The method pairs a single precipitation step with LC-MS\/MS analysis using a Raptor Biphenyl column. A fast, 3-minute analysis time was obtained with no interference from matrix components. Excellent results were obtained for linearity, robustness, accuracy, and precision, demonstrating that the method is suitable for high-throughput therapeutic drug monitoring.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Introduction<\/h2>\n\n\n\n<p>Immunosuppressive drugs are used to suppress the body\u2019s immune response and are typically administered to prevent the rejection of transplanted organs or tissues. Cyclosporin A, tacrolimus, sirolimus, and everolimus are four of the most commonly used drugs in the therapy of organ transplantation. Their structures are shown in Figure 1. Cyclosporin A and tacrolimus are classified as calcineurin inhibitors, and sirolimus and everolimus are grouped as mTOR inhibitors. These two classes of drugs can be used in combination for synergistic blocking of T cell activation and proliferation. Due to their pharmacokinetic variabilities and narrow therapeutic indexes, time-sensitive and highly accurate therapeutic drug monitoring is necessary, not only to prevent rejection but also to minimize toxic side effects. Therefore, a fast and accurate measurement of drug concentration is critical to assist clinicians with timely and proper treatment of patients.<\/p>\n\n\n\n<p>Several commercial products are available for the simultaneous analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood. However, most of these commercial kits require an additional in-line trap column or SPE sample cleanup prior to chromatographic analysis. Here, we reduced sample preparation time and effort by pairing a single precipitation step with a Raptor Biphenyl analytical column. This analytical column was chosen because it provides suitable retention and selectivity for these compounds so that a short analysis time (3 minutes) can be achieved without encountering matrix interference. By combining a simple sample preparation step and a fast chromatographic elution, a high-throughput analysis was established for the simultaneous analysis of four immunosuppressive drugs in human whole blood.<\/p>\n\n\n<div class=\"wp-block-custom-chromatogram-article-top\"><div class=\"chromatogram-article-placeholder\"><div class=\"figure-heading\"><strong>Figure 1:<\/strong>\u00a0Analyte Structures.<\/div><div class='chromatogram-article-inner-full'><div class=\"chromatogram-article-inner\">\n<style>.kb-image43344_a8bd59-e5 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image43344_a8bd59-e5\"><figure class=\"aligncenter size-medium_large\"><img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"612\" src=\"https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01-768x612.jpg\" alt=\"\" class=\"kb-img wp-image-18892\" title=\"-\" srcset=\"https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01-768x612.jpg 768w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01-300x239.jpg 300w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01-1024x816.jpg 1024w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01-1536x1225.jpg 1536w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-01.jpg 1800w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/figure><\/div>\n\n<\/div><\/div><\/div>\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"wp-block-heading\">Experimental<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Calibration Standards and Blood Control Samples<\/h3>\n\n\n\n<p>Human whole blood was fortified with four immunosuppressive drugs to prepare the calibration standards and QC samples. For quantitation, cyclosporin D was used as the internal standard for cyclosporin A, and ascomycin was used as the internal standard for tacrolimus, sirolimus, and everolimus. The general therapeutic ranges are 25\u2013400 ng\/mL for cyclosporin A, 5\u201320 ng\/mL for tacrolimus and sirolimus, and 3\u20138 ng\/mL for everolimus. Accordingly, the calibration standard ranges were evaluated from 10 to 1,000 ng\/mL for cyclosporin A and from 1 to 100 ng\/mL for tacrolimus, sirolimus, and everolimus. Three QC levels were prepared: 15, 150, and 800 ng\/mL for cyclosporin A and 5, 15, and 80 ng\/mL for tacrolimus, sirolimus, and everolimus.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Sample Preparation<\/h3>\n\n\n\n<p>Each blood sample (100 \u00b5L) was mixed with 200 \u00b5L of precipitation solution [1:4 (v\/v) 0.2 M ZnSO4:methanol] containing 50 ng\/mL of cyclosporin D and 5 ng\/mL of ascomycin. The mixture was vortexed for 20 seconds at 3,000 rpm and then centrifuged for 10 minutes at 4,300 rpm. The supernatant was directly injected (5 \u00b5L) onto a Raptor Biphenyl (2.7 \u00b5m, 50 mm x 2.1 mm) column equipped with a Raptor Biphenyl EXP (2.7 \u00b5m, 5 mm x 2.1 mm) guard column for analysis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">LC-MS\/MS Analysis<\/h3>\n\n\n\n<p>Analysis of immunosuppressive drugs (cyclosporin A, tacrolimus, sirolimus, and everolimus) was conducted using a Waters Xevo TQ-S mass spectrometer with an ACQUITY UPLC under the conditions shown below. The analyte transitions that were monitored are presented in Table I.<\/p>\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\" style=\"border-style: none;\"><tbody><tr><td>Analytical column:<\/td><td colspan=\"2\">Raptor Biphenyl, 2.7 \u00b5m, 50 mm x 2.1 mm (cat.# 9309A52)<\/td><\/tr><tr><td>Guard column:<\/td><td colspan=\"2\">Raptor Biphenyl EXP, 2.7 \u00b5m, 5 mm x 2.1 mm (cat.# 9309A0252)<\/td><\/tr><tr><td>Mobile phase A:<\/td><td colspan=\"2\">0.05% Formic acid, 5 mM ammonium formate in water<\/td><\/tr><tr><td>Mobile phase B:<\/td><td colspan=\"2\">Methanol<\/td><\/tr><tr><td>Gradient<\/td><td>Time (min)<\/td><td>%B<\/td><\/tr><tr><td>&nbsp;<\/td><td>0.00<\/td><td>60<\/td><\/tr><tr><td>&nbsp;<\/td><td>2.00<\/td><td>100<\/td><\/tr><tr><td>&nbsp;<\/td><td>2.01<\/td><td>60<\/td><\/tr><tr><td>&nbsp;<\/td><td>3.00<\/td><td>60<\/td><\/tr><tr><td>Flow rate:<\/td><td colspan=\"2\">0.5 mL\/min<\/td><\/tr><tr><td>Injection volume:<\/td><td colspan=\"2\">5 \u00b5L<\/td><\/tr><tr><td>Column temp.:<\/td><td colspan=\"2\">70 \u00b0C<\/td><\/tr><tr><td>Ion mode:<\/td><td colspan=\"2\">Positive ESI<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Table I:<\/strong>&nbsp;Analyte Transitions<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th><strong>Analyte<\/strong><\/th><th><strong>Precursor Ion<\/strong><\/th><th><strong>Product Ion Quantifier<\/strong><\/th><th><strong>Product Ion Qualifier<\/strong><\/th><\/tr><\/thead><tbody><tr><td>Cyclosporin A<\/td><td>1219.83<\/td><td>1202.87<\/td><td>1184.58<\/td><\/tr><tr><td>Everolimus<\/td><td>975.68<\/td><td>908.62<\/td><td>926.57<\/td><\/tr><tr><td>Sirolimus<\/td><td>931.63<\/td><td>864.57<\/td><td>882.58<\/td><\/tr><tr><td>Tacrolimus<\/td><td>821.61<\/td><td>768.51<\/td><td>786.52<\/td><\/tr><tr><td>Cyclosporin D<\/td><td>1233.91<\/td><td>1216.88<\/td><td>&#8211;<\/td><\/tr><tr><td>Ascomycin<\/td><td>809.53<\/td><td>756.50<\/td><td>&#8211;<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Results and Discussion<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Chromatographic Performance<\/h3>\n\n\n\n<p>A fast 3-minute chromatographic analysis of all four immunosuppressive drugs (Figure 2) was achieved with direct injection of the supernatant without any further in- or off-line sample treatment. No matrix interference was observed for all four analytes and internal standards (Figure 3) with the established sample preparation and chromatographic methods. The Raptor Biphenyl column provided more retention than a C18 phase and less retention than a fluorophenyl phase, resulting in optimum retention and selectivity for cyclosporin A, tacrolimus, sirolimus, and everolimus.<\/p>\n\n\n<div class=\"wp-block-custom-chromatogram-article-top\"><div class=\"chromatogram-article-placeholder\"><div class=\"figure-heading\"><strong>Figure 2:<\/strong>\u00a0Fortified Human Whole Blood at 10 ng\/mL.<\/div><div class='chromatogram-article-inner-full'><div class=\"chromatogram-article-inner\">\n<div class=\"wp-block-custom-chromatogram-article\"><div class=\"wp-block-custom-chromatogram-article\"><div class=\"chromatogram-image regular-image\"><img decoding=\"async\" src=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0686.png\" alt=\"Immunosuppressive Drugs in Blood on Raptor Biphenyl by LC-MS\/MS\" title=\"-\"><\/div><p class=\"article-id\" style=\"text-align:center\"> LC_CF0686<\/p><div class=\"chromatogram-peaks\"><h4>Peaks<\/h4><table class=\"peaks col-lg-6 col-12\">\n<thead><tr><th><\/th><th style=\"text-align: left;width: 75px\">Peaks<\/th><th style=\"text-align: center;width: 75px\">t<sub>R<\/sub> (min)<\/th><th style=\"text-align: center;width: 75px\">Conc.<br \/>(ng\/mL)<\/th><th style=\"text-align: center;width: 75px\">Precursor Ion<\/th><th style=\"text-align: center;width: 75px\">Product Ion<\/th><\/tr><\/thead>\n<tbody><tr><td class=\"num\">1.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Ascomycin\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/11011-38-4\/Ascomycin\" target=\"_blank\" rel=\"noopener\">Ascomycin<\/a><\/td><td class=\"oth\">1.45<\/td><td class=\"oth\">10<\/td><td class=\"oth\">809.53<\/td><td class=\"oth\">756.50<\/td><\/tr>\n<tr><td class=\"num\">2.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Tacrolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/104987-11-3\/Tacrolimus\" target=\"_blank\" rel=\"noopener\">Tacrolimus<\/a><\/td><td class=\"oth\">1.47<\/td><td class=\"oth\">10<\/td><td class=\"oth\">821.61<\/td><td class=\"oth\">768.51<\/td><\/tr>\n<tr><td class=\"num\">3.<\/td><td class=\"cmpd\">Sirolimus<\/td><td class=\"oth\">1.64<\/td><td class=\"oth\">10<\/td><td class=\"oth\">931.63<\/td><td class=\"oth\">864.57<\/td><\/tr>\n<tr><td class=\"num\">4.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Everolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/159351-69-6\/Everolimus\" target=\"_blank\" rel=\"noopener\">Everolimus<\/a><\/td><td class=\"oth\">1.69<\/td><td class=\"oth\">10<\/td><td class=\"oth\">975.68<\/td><td class=\"oth\">908.62<\/td><\/tr>\n<tr><td class=\"num\">5.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin A\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/59865-13-3\/Cyclosporin A\" target=\"_blank\" rel=\"noopener\">Cyclosporin A<\/a><\/td><td class=\"oth\">1.83<\/td><td class=\"oth\">10<\/td><td class=\"oth\">1219.83<\/td><td class=\"oth\">1202.87<\/td><\/tr>\n<tr><td class=\"num\">6.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin D\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/63775-96-2\/Cyclosporin D\" target=\"_blank\" rel=\"noopener\">Cyclosporin D<\/a><\/td><td class=\"oth\">1.89<\/td><td class=\"oth\">100<\/td><td class=\"oth\">1233.91<\/td><td class=\"oth\">1216.88<\/td><\/tr>\n<\/tbody><\/table><\/div><div class=\"chromatogram-pdf-link\"><a href=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0686.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 18 18\"><g data-name=\"Group 2996\"><path data-name=\"Rectangle 1246\" d=\"M0 0h18v18H0z\" style=\"fill: none;\"><\/path><\/g><g data-name=\"Group 2997\"><path data-name=\"Path 729\" d=\"M13.412 11.4v2.017H5.345V11.4H4v2.017a1.349 1.349 0 0 0 1.345 1.345h8.068a1.349 1.349 0 0 0 1.345-1.345V11.4zm-.672-2.694-.948-.948-1.741 1.735V4H8.706v5.493L6.965 7.758l-.948.948 3.361 3.361z\" transform=\"translate(-.437 -.414)\" style=\"fill: rgb(13, 123, 196);\"><\/path><\/g><\/svg>Download PDF<\/a><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n\n<div class=\"wp-block-custom-chromatogram-article-top\"><div class=\"chromatogram-article-placeholder\"><div class=\"figure-heading\"><strong>Figure 3:<\/strong>\u00a0Blank Human Whole Blood.<\/div><div class='chromatogram-article-inner-full'><div class=\"chromatogram-article-inner\">\n<div class=\"wp-block-custom-chromatogram-article\"><div class=\"wp-block-custom-chromatogram-article\"><div class=\"chromatogram-image regular-image\"><img decoding=\"async\" src=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0687.png\" alt=\"Blank Blood Analysis for Immunosuppressive Drugs Method Validation\" title=\"-\"><\/div><p class=\"article-id\" style=\"text-align:center\"> LC_CF0687<\/p><div class=\"chromatogram-peaks\"><h4>Peaks<\/h4><table class=\"peaks col-lg-6 col-12\">\n<thead><tr><th><\/th><th style=\"text-align: left;width: 75px\">Peaks<\/th><th style=\"text-align: center;width: 75px\">Conc.<br \/>(ng\/mL)<\/th><th style=\"text-align: center;width: 75px\">Precursor Ion<\/th><th style=\"text-align: center;width: 75px\">Product Ion<\/th><\/tr><\/thead>\n<tbody><tr><td class=\"num\">1.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Ascomycin\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/11011-38-4\/Ascomycin\" target=\"_blank\" rel=\"noopener\">Ascomycin<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">809.53<\/td><td class=\"oth\">756.50<\/td><\/tr>\n<tr><td class=\"num\">2.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Tacrolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/104987-11-3\/Tacrolimus\" target=\"_blank\" rel=\"noopener\">Tacrolimus<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">821.61<\/td><td class=\"oth\">768.51<\/td><\/tr>\n<tr><td class=\"num\">3.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Sirolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/53123-88-9\/Sirolimus\" target=\"_blank\" rel=\"noopener\">Sirolimus<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">931.63<\/td><td class=\"oth\">864.57<\/td><\/tr>\n<tr><td class=\"num\">4.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Everolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/159351-69-6\/Everolimus\" target=\"_blank\" rel=\"noopener\">Everolimus<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">975.68<\/td><td class=\"oth\">908.62<\/td><\/tr>\n<tr><td class=\"num\">5.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin A\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/59865-13-3\/Cyclosporin A\" target=\"_blank\" rel=\"noopener\">Cyclosporin A<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">1219.83<\/td><td class=\"oth\">1202.87<\/td><\/tr>\n<tr><td class=\"num\">6.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin D\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/63775-96-2\/Cyclosporin D\" target=\"_blank\" rel=\"noopener\">Cyclosporin D<\/a><\/td><td class=\"oth\">0<\/td><td class=\"oth\">1233.91<\/td><td class=\"oth\">1216.88<\/td><\/tr>\n<\/tbody><\/table><\/div><div class=\"chromatogram-pdf-link\"><a href=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0687.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 18 18\"><g data-name=\"Group 2996\"><path data-name=\"Rectangle 1246\" d=\"M0 0h18v18H0z\" style=\"fill: none;\"><\/path><\/g><g data-name=\"Group 2997\"><path data-name=\"Path 729\" d=\"M13.412 11.4v2.017H5.345V11.4H4v2.017a1.349 1.349 0 0 0 1.345 1.345h8.068a1.349 1.349 0 0 0 1.345-1.345V11.4zm-.672-2.694-.948-.948-1.741 1.735V4H8.706v5.493L6.965 7.758l-.948.948 3.361 3.361z\" transform=\"translate(-.437 -.414)\" style=\"fill: rgb(13, 123, 196);\"><\/path><\/g><\/svg>Download PDF<\/a><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Method Robustness<\/h3>\n\n\n\n<p>Following 500 injections of a prepared whole blood standard (25 ng\/mL), the chromatographic peaks of all four immunosuppressive drug analytes maintained the initial peak shape, retention time, and intensity (Figure 4). The maximum system pressure also remained at the same level, indicating no column clogging had occurred.<\/p>\n\n\n<div class=\"wp-block-custom-chromatogram-article-top\"><div class=\"chromatogram-article-placeholder\"><div class=\"figure-heading\"><strong>Figure 4:<\/strong>\u00a0Robust Column Performance Over 500 Injections.<\/div><div class='chromatogram-article-inner-full'><div class=\"chromatogram-article-inner\">\n<div class=\"wp-block-custom-chromatogram-article\"><div class=\"wp-block-custom-chromatogram-article\"><div class=\"chromatogram-image regular-image\"><img decoding=\"async\" src=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0688.png\" alt=\"Column Lifetime Evaluation for Immunosuppressive Drug Analysis\" title=\"-\"><\/div><p class=\"article-id\" style=\"text-align:center\"> LC_CF0688<\/p><div class=\"chromatogram-peaks\"><h4>Peaks<\/h4><table class=\"peaks col-lg-6 col-12\">\n<thead><tr><th><\/th><th style=\"text-align: left;width: 75px\">Peaks<\/th><th style=\"text-align: center;width: 75px\">Conc.<br \/>(ng\/mL)<\/th><th style=\"text-align: center;width: 75px\">Precursor Ion<\/th><th style=\"text-align: center;width: 75px\">Product Ion<\/th><\/tr><\/thead>\n<tbody><tr><td class=\"num\">1.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Ascomycin\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/11011-38-4\/Ascomycin\" target=\"_blank\" rel=\"noopener\">Ascomycin<\/a><\/td><td class=\"oth\">10<\/td><td class=\"oth\">809.53<\/td><td class=\"oth\">756.50<\/td><\/tr>\n<tr><td class=\"num\">2.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Tacrolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/104987-11-3\/Tacrolimus\" target=\"_blank\" rel=\"noopener\">Tacrolimus<\/a><\/td><td class=\"oth\">25<\/td><td class=\"oth\">821.61<\/td><td class=\"oth\">768.51<\/td><\/tr>\n<tr><td class=\"num\">3.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Sirolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/53123-88-9\/Sirolimus\" target=\"_blank\" rel=\"noopener\">Sirolimus<\/a><\/td><td class=\"oth\">25<\/td><td class=\"oth\">931.63<\/td><td class=\"oth\">864.57<\/td><\/tr>\n<tr><td class=\"num\">4.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Everolimus\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/159351-69-6\/Everolimus\" target=\"_blank\" rel=\"noopener\">Everolimus<\/a><\/td><td class=\"oth\">25<\/td><td class=\"oth\">975.68<\/td><td class=\"oth\">908.62<\/td><\/tr>\n<tr><td class=\"num\">5.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin A\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/59865-13-3\/Cyclosporin A\" target=\"_blank\" rel=\"noopener\">Cyclosporin A<\/a><\/td><td class=\"oth\">25<\/td><td class=\"oth\">1219.83<\/td><td class=\"oth\">1202.87<\/td><\/tr>\n<tr><td class=\"num\">6.<\/td><td class=\"cmpd\"><a class=\"cmpd_link\" title=\"View compound information for Cyclosporin D\" href=\"https:\/\/ez.restek.com\/compound\/view\/en\/63775-96-2\/Cyclosporin D\" target=\"_blank\" rel=\"noopener\">Cyclosporin D<\/a><\/td><td class=\"oth\">100<\/td><td class=\"oth\">1233.91<\/td><td class=\"oth\">1216.88<\/td><\/tr>\n<\/tbody><\/table><div class=\"peaknotes\">See chromatograms for retention times.<\/div><\/div><div class=\"chromatogram-conditions\"><h4>Conditions<\/h4><div class=\"conditions-container container-fluid\"><div class=\"row\"><table class=\"conditions col-lg-6 col-12\"><tr><th class=\"conditions_header\" scope=\"row\">Column<\/th><td>Raptor Biphenyl  (<a target=\"_blank\" href=\"https:\/\/www.restek.com\/p\/9309A52?utm_source=chromatograms&amp;utm_medium=link&amp;utm_campaign=LC_CF0688\" rel=\"noopener\">cat.# 9309A52<\/a>)<\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Dimensions:<\/th><td>50 mm x 2.1 mm ID<\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Particle Size:<\/th><td>2.7 \u00b5m<\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Pore Size:<\/th><td>90 \u00c5<\/td><\/tr><tr><td><\/td><tr><th class=\"sub conditions_header\" scope=\"row\">Guard Column:<\/th><td>Raptor Biphenyl EXP guard column cartridge 5 mm, 2.1 mm ID, 2.7 \u00b5m (<a target=\"_blank\" href=\"https:\/\/www.restek.com\/p\/9309A0252?utm_source=chromatograms&amp;utm_medium=link&amp;utm_campaign=LC_CF0688\" rel=\"noopener\">cat.# 9309A0252<\/a>)<\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Temp.:<\/th><td>70 \u00b0C<\/td><\/tr><tr class=\"cgram_header_row\"><th class=\"conditions_header\" scope=\"row\">Standard\/Sample<\/th><td><\/td><\/tr><td><\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Inj. Vol.:<\/th><td>5 \u00b5L <\/td><\/tr><tr class=\"cgram_header_row\"><th class=\"conditions_header\" scope=\"row\">Mobile Phase<\/th><td><\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">A:<\/th><td>0.05% Formic acid, 5 mM ammonium formate in water <\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">B:<\/th><td>Methanol <\/td><\/tr><tr><td><\/td><td><table class=\"cgram_ramp\"><thead><tr><th>Time (min)<\/th><th>Flow (mL\/min)<\/th><th>%A<\/th><th>%B<\/th><\/tr><\/thead><tbody><tr><td>0.00<\/td><td>0.5<\/td><td>40<\/td><td>60<\/td><\/tr><tr><td>2.00<\/td><td>0.5<\/td><td>0<\/td><td>100<\/td><\/tr><tr><td>2.01<\/td><td>0.5<\/td><td>40<\/td><td>60<\/td><\/tr><tr><td>3.00<\/td><td>0.5<\/td><td>40<\/td><td>60<\/td><\/tr><\/tbody><\/table><\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Max Pressure:<\/th><td>305 bar<\/td><\/tr><\/table><table class=\"conditions col-lg-6 col-12\"><tr><th class=\"conditions_header\" scope=\"row\">Detector<\/th><td>MS\/MS<\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Ion Mode:<\/th><td>ESI+ <\/td><\/tr><tr><th class=\"sub conditions_header\" scope=\"row\">Mode:<\/th><td>MRM <\/td><\/tr><tr class=\"cgram_header_row\"><th class=\"conditions_header\" scope=\"row\">Instrument<\/th><td>57I<\/td><\/tr><tr class=\"cgram_header_row\"><th class=\"conditions_header\" scope=\"row\">Sample Preparation<\/th><td>Human whole blood was fortified with 4 analytes at 25 ng\/mL. For quantitation, cyclosporin D was used as the internal standard for cyclosporin A and ascomycin was used as the internal standard for tacrolimus, sirolimus, and everolimus. The blood sample (2.5 mL) was mixed with 5 mL of precipitation solution (1:4 v\/v 0.2 M ZnSO<sub>4<\/sub>:methanol) containing 50 ng\/mL of cyclosporin D and 5 ng\/mL of ascomycin. The mixture was vortexed for 20 seconds at 3000 rpm and then centrifuged for 10 minutes at 4300 rpm. The supernatant was directly injected (5 \u03bcL) for analysis.<\/td><\/tr><\/table><\/div><\/div><\/div><div class=\"chromatogram-pdf-link\"><a href=\"https:\/\/ez.restek.com\/images\/cgram\/lc_cf0688.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"18\" height=\"18\" viewBox=\"0 0 18 18\"><g data-name=\"Group 2996\"><path data-name=\"Rectangle 1246\" d=\"M0 0h18v18H0z\" style=\"fill: none;\"><\/path><\/g><g data-name=\"Group 2997\"><path data-name=\"Path 729\" d=\"M13.412 11.4v2.017H5.345V11.4H4v2.017a1.349 1.349 0 0 0 1.345 1.345h8.068a1.349 1.349 0 0 0 1.345-1.345V11.4zm-.672-2.694-.948-.948-1.741 1.735V4H8.706v5.493L6.965 7.758l-.948.948 3.361 3.361z\" transform=\"translate(-.437 -.414)\" style=\"fill: rgb(13, 123, 196);\"><\/path><\/g><\/svg>Download PDF<\/a><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Linearity<\/h3>\n\n\n\n<p>Using a 1\/x<sup>2<\/sup>&nbsp;weighted linear regression for cyclosporin A and a 1\/x weighted linear regression for tacrolimus, sirolimus, and everolimus, all four immunosuppressive drug compounds showed very good linearity with r values of 0.999 or greater, and with deviations of &lt;10% (Figure 5). The signal-to-noise values of the lowest standard samples were from 100 to 300, indicating that this method could be used for the detection of much lower concentrations if necessary.<\/p>\n\n\n<div class=\"wp-block-custom-chromatogram-article-top\"><div class=\"chromatogram-article-placeholder\"><div class=\"figure-heading\"><strong>Figure 5:<\/strong>\u00a0Standard Curves.<\/div><div class='chromatogram-article-inner-full'><div class=\"chromatogram-article-inner\">\n<style>.kb-image43344_c3337c-c2 .kb-image-has-overlay:after{opacity:0.3;}<\/style>\n<div class=\"wp-block-kadence-image kb-image43344_c3337c-c2\"><figure class=\"aligncenter size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"630\" src=\"https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05-1024x630.jpg\" alt=\"\" class=\"kb-img wp-image-18898\" title=\"-\" srcset=\"https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05-1024x630.jpg 1024w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05-300x185.jpg 300w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05-768x472.jpg 768w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05-1536x945.jpg 1536w, https:\/\/discover.restek.com\/wp-content\/uploads\/figure-article-CFAN2666-05.jpg 1800w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n<\/div><\/div><\/div>\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Accuracy and Precision<\/h3>\n\n\n\n<p>Precision and accuracy analyses were performed on three different days. Method accuracy was demonstrated with recovery values that were within 10% of the nominal concentration for all QC levels. The %RSD across all analytes and fortification levels was 0.2\u20134.0% and 1.2\u20135.4% for intraday and interday evaluations respectively, indicating good method precision (Table II).<\/p>\n\n\n\n<p><strong>Table II:<\/strong>&nbsp;Accuracy and Precision of QC Samples<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td>&nbsp;<\/td><td colspan=\"3\"><strong>QC Level 1 (5.0 ng\/mL)<br>(Cyclosporin A: 15 ng\/mL)<\/strong><\/td><td colspan=\"3\"><strong>QC Level 2 (15.0 ng\/mL)<br>(Cyclosporin A: 150 ng\/mL)<\/strong><\/td><td colspan=\"3\"><strong>QC Level 3 (80 ng\/mL)<br>(Cyclosporin A: 800 ng\/mL)<\/strong><\/td><\/tr><tr><td><strong>Analyte<\/strong><\/td><td><strong>Average Conc. (ng\/mL)<\/strong><\/td><td><strong>Average Accuracy (%)<\/strong><\/td><td><strong>%RSD<\/strong><\/td><td><strong>Average Conc. (ng\/mL)<\/strong><\/td><td><strong>Average Accuracy (%)<\/strong><\/td><td><strong>%RSD<\/strong><\/td><td><strong>Average Conc. (ng\/mL)<\/strong><\/td><td><strong>Average Accuracy (%)<\/strong><\/td><td><strong>%RSD<\/strong><\/td><\/tr><tr><td>Cyclosporin A<\/td><td>15.0<\/td><td>99.9<\/td><td>5.4<\/td><td>152.3<\/td><td>101.5<\/td><td>1.2<\/td><td>795.6<\/td><td>99.5<\/td><td>2.1<\/td><\/tr><tr><td>Tacrolimus<\/td><td>5.2<\/td><td>103.6<\/td><td>1.8<\/td><td>14.3<\/td><td>95.1<\/td><td>1.9<\/td><td>81.8<\/td><td>102.3<\/td><td>1.3<\/td><\/tr><tr><td>Sirolimus<\/td><td>5.2<\/td><td>103.9<\/td><td>4.3<\/td><td>14.4<\/td><td>96.2<\/td><td>2.7<\/td><td>83.0<\/td><td>103.7<\/td><td>2.1<\/td><\/tr><tr><td>Everolimus<\/td><td>5.1<\/td><td>101.1<\/td><td>2.0<\/td><td>14.2<\/td><td>94.8<\/td><td>2.1<\/td><td>80.8<\/td><td>101.0<\/td><td>2.8<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p>It was demonstrated that the Raptor Biphenyl column provides excellent chromatographic performance for the rapid and accurate analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in human whole blood. With a fast and simple sample preparation procedure and a 3-minute analysis time, the method established here provides high-throughput therapeutic drug monitoring for these commonly used immunosuppressive drugs.<\/p>\n\n\n\n<div style=\"height:30px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n        <div class=\"cpb\">\n            <h3 class=\"cpb-heading\">Products Mentioned<\/h3>\n            <hr class=\"cpb-heading-underline\" \/>\n            <div class=\"cpb-list\">\n                                    <div class=\"cpb-item\">\n                        <div class=\"cpb-col cpb-col--left\">\n                            <a class=\"cpb-catalog\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/de.restek.com\/p\/9309A52\">                                Catalog No. 9309A52                            <\/a>                        <\/div>\n                        <div class=\"cpb-col cpb-col--middle\">\n                            <div class=\"cpb-title\">Raptor Biphenyl, 2.7 \u00b5m, 50&#215;2.1 mm HPLC-S\u00e4ule<\/div>\n                        <\/div>\n                        <div class=\"cpb-col cpb-col--right\">\n                                                            <a class=\"cpb-view-btn\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/de.restek.com\/p\/9309A52\">Produkt anzeigen<\/a>\n                                                    <\/div>\n                    <\/div>\n                                    <div class=\"cpb-item\">\n                        <div class=\"cpb-col cpb-col--left\">\n                            <a class=\"cpb-catalog\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/de.restek.com\/p\/9309A0252\">                                Catalog No. 9309A0252                            <\/a>                        <\/div>\n                        <div class=\"cpb-col cpb-col--middle\">\n                            <div class=\"cpb-title\">Raptor Biphenyl EXP Vors\u00e4ulenkartusche, 2.7 \u00b5m, 5 x 2.1 mm, 3er Pack<\/div>\n                        <\/div>\n                        <div class=\"cpb-col cpb-col--right\">\n                                                            <a class=\"cpb-view-btn\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/de.restek.com\/p\/9309A0252\">Produkt anzeigen<\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n        <\/div>\n        \n\n\n<div style=\"height:100px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The success of organ transplant therapy depends in large part on the accurate and timely analysis of immunosuppressive drugs. In this study, we developed a fast, accurate method for cyclosporin A, tacrolimus, sirolimus, and everolimus in whole blood. The method pairs a single protein precipitation step with LC-MS\/MS analysis using a Raptor Biphenyl column. A fast, 3-minute analysis time was obtained with no interference from matrix components. Excellent results were obtained for linearity, robustness, accuracy, and precision, demonstrating that the method is suitable for high-throughput therapeutic drug monitoring.<\/p>\n","protected":false},"author":46,"featured_media":6337,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_kad_blocks_custom_css":"","_kad_blocks_head_custom_js":"","_kad_blocks_body_custom_js":"","_kad_blocks_footer_custom_js":"","_kadence_starter_templates_imported_post":false,"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[784],"tags":[],"industries-application":[2245],"post-badge":[],"resource-type":[],"product-library":[2516,2528,2543,2518],"resource-technique":[2334,2364],"hf_cat_post":[651],"ppma_author":[578,586],"class_list":["post-43344","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-application-notes-it","industries-application-clinico","product-library-prodotti-per-gascromatografia","product-library-colonne-gc","product-library-standard-di-riferimento-liquidi","product-library-standard-di-riferimento","resource-technique-cromatografia-liquida-lc","resource-technique-ms-ms-it"],"acf":[],"taxonomy_info":{"category":[{"value":784,"label":"Application Notes"}],"industries-application":[{"value":2245,"label":"Clinico"}],"product-library":[{"value":2516,"label":"Prodotti per Gascromatografia"},{"value":2528,"label":"Colonne GC"},{"value":2543,"label":"Standard di Riferimento Liquidi"},{"value":2518,"label":"Standard di Riferimento"}],"resource-technique":[{"value":2334,"label":"Cromatografia Liquida (LC)"},{"value":2364,"label":"MS\/MS"}]},"featured_image_src_large":["https:\/\/discover.restek.com\/wp-content\/uploads\/feature-CFAN2666-1024x536.jpg",1024,536,true],"author_info":{"display_name":"Shun-Hsin Liang, PhD","author_link":"https:\/\/discover.restek.com\/de\/author\/shun-hsin-liang-phd\/"},"comment_info":0,"category_info":[{"term_id":784,"name":"Application Notes","slug":"application-notes-it","term_group":0,"term_taxonomy_id":784,"taxonomy":"category","description":"","parent":0,"count":86,"filter":"raw","cat_ID":784,"category_count":86,"category_description":"","cat_name":"Application Notes","category_nicename":"application-notes-it","category_parent":0}],"tag_info":false,"authors":[{"term_id":578,"user_id":46,"is_guest":0,"slug":"shun-hsin-liang-phd","display_name":"Shun-Hsin Liang, PhD","avatar_url":{"url":"https:\/\/discover.restek.com\/wp-content\/uploads\/people-liang-shun-hsin-e1765414149534.png","url2x":"https:\/\/discover.restek.com\/wp-content\/uploads\/people-liang-shun-hsin-e1765414149534.png"},"0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":586,"user_id":0,"is_guest":1,"slug":"frances-carroll","display_name":"Frances Carroll","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&d=mm&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/posts\/43344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/comments?post=43344"}],"version-history":[{"count":4,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/posts\/43344\/revisions"}],"predecessor-version":[{"id":73938,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/posts\/43344\/revisions\/73938"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/media\/6337"}],"wp:attachment":[{"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/media?parent=43344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/categories?post=43344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/tags?post=43344"},{"taxonomy":"industries-application","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/industries-application?post=43344"},{"taxonomy":"post-badge","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/post-badge?post=43344"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/resource-type?post=43344"},{"taxonomy":"product-library","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/product-library?post=43344"},{"taxonomy":"resource-technique","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/resource-technique?post=43344"},{"taxonomy":"hf_cat_post","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/hf_cat_post?post=43344"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/discover.restek.com\/de\/wp-json\/wp\/v2\/ppma_author?post=43344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}